Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

MYO-MRI diagnostic protocols in genetic myopathies

Research output: Contribution to journalReviewResearchpeer-review

  1. Results of an open label feasibility study of sodium valproate in people with McArdle disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Contractile properties are impaired in congenital myopathies

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. BAG3 myopathy is not always associated with cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Phenotypic Spectrum of α-Dystroglycanopathies Associated With the c.919T>a Variant in the FKRP Gene in Humans and Mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vacuoles, Often Containing Glycogen, Are a Consistent Finding in Hypokalemic Periodic Paralysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Editorial: Remaining diagnostic issues and start of a treatment era for muscle diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jodi Warman Chardon
  • Jordi Díaz-Manera
  • Giorgio Tasca
  • Carsten G Bönnemann
  • David Gómez-Andrés
  • Arend Heerschap
  • Eugenio Mercuri
  • Francesco Muntoni
  • Anna Pichiecchio
  • Enzo Ricci
  • Maggie C Walter
  • Michael Hanna
  • Heinz Jungbluth
  • Jasper M Morrow
  • Roberto Fernández Torrón
  • Bjarne Udd
  • John Vissing
  • Tarek Yousry
  • Susana Quijano-Roy
  • Volker Straub
  • Robert Y Carlier
  • MYO-MRI Working Group
View graph of relations

Whole-body magnetic resonance imaging has emerged as a useful imaging tool in diagnosing and characterizing the progression of myopathies and muscular dystrophies. Whole-body MRI indications and diagnostic efficacy are becoming better defined with the increasing number of cases, publications and discussions within multidisciplinary working groups. Advanced Whole-body MRI protocols are rapid, lower cost, and well-tolerated by patients. Accurate interpretation of muscle Whole-body MRI requires a detailed knowledge of muscle anatomy and differential pattern of involvement in muscle diseases. With the surge in recently identified novel genetic myopathies, Whole-body MRI will become increasingly useful for phenotypic validation of genetic variants of unknown significance. In addition, Whole-body MRI will be progressively used as a biomarker for disease progression and quantify response to therapy with the emergence of novel disease modifying treatments. This review outlines Whole-body MRI indications and updates refined protocols and provides a comprehensive overview of the diagnostic utility and suggested methodology of Whole-body MRI for pediatric and adult patients with muscle diseases.

Original languageEnglish
JournalNeuromuscular disorders : NMD
Volume29
Issue number11
Pages (from-to)827-841
Number of pages15
ISSN0960-8966
DOIs
Publication statusPublished - 2019

    Research areas

  • Congenital myopathy, Inflammatory myopathy, Inherited myopathy, Limb girdle muscular dystrophy, Magnetic resonance imaging, Whole-body MRI

ID: 58451448